Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1231168.RAQM4lULCBZs74eS4PbXcgfmPXFs0SujdeM1kfxdYpnoA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1231168.RAQM4lULCBZs74eS4PbXcgfmPXFs0SujdeM1kfxdYpnoA130_assertion type Assertion NP1231168.RAQM4lULCBZs74eS4PbXcgfmPXFs0SujdeM1kfxdYpnoA130_head.
- NP1231168.RAQM4lULCBZs74eS4PbXcgfmPXFs0SujdeM1kfxdYpnoA130_assertion description "[In addition, loss of Smad4 staining was more likely to be found in older (OR?=?1.69, 95% CI: 1.09-2.61; Pheterogeneity?=?0.648) colorectal cancer patients with a late tumor stage (OR?=?2.31, 95% CI: 1.71-3.10; Pheterogeneity?=?0.218) and in gastric cancer patients with lymph node metastasis (OR?=?2.11, 95% CI: 1.03-4.34; Pheterogeneity?=?0.038).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1231168.RAQM4lULCBZs74eS4PbXcgfmPXFs0SujdeM1kfxdYpnoA130_provenance.
- NP1231168.RAQM4lULCBZs74eS4PbXcgfmPXFs0SujdeM1kfxdYpnoA130_assertion evidence source_evidence_literature NP1231168.RAQM4lULCBZs74eS4PbXcgfmPXFs0SujdeM1kfxdYpnoA130_provenance.
- NP1231168.RAQM4lULCBZs74eS4PbXcgfmPXFs0SujdeM1kfxdYpnoA130_assertion SIO_000772 25333693 NP1231168.RAQM4lULCBZs74eS4PbXcgfmPXFs0SujdeM1kfxdYpnoA130_provenance.
- NP1231168.RAQM4lULCBZs74eS4PbXcgfmPXFs0SujdeM1kfxdYpnoA130_assertion wasDerivedFrom befree-2016 NP1231168.RAQM4lULCBZs74eS4PbXcgfmPXFs0SujdeM1kfxdYpnoA130_provenance.
- NP1231168.RAQM4lULCBZs74eS4PbXcgfmPXFs0SujdeM1kfxdYpnoA130_assertion wasGeneratedBy ECO_0000203 NP1231168.RAQM4lULCBZs74eS4PbXcgfmPXFs0SujdeM1kfxdYpnoA130_provenance.